SCHEMBL7355240

SCHEMBL7355240

O=C(NC1CC1)c1cccc2c1ncn2CCCCN1CC=C(c2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.44
DRD3 P35462 3/20 0.44
DRD2 P14416 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
PARP1 P09874 4/20 0.42
SIGMAR1 Q99720 2/20 0.42
DRD4 P21917 3/20 0.41
HTR2A P28223 1/20 0.40
HTR7 P34969 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
HTR2B P41595 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7360005 0.86 HTR1A (0.45) HTR1ADRD3DRD2KDM4EPARP1
SCHEMBL7354368 0.84 HTR1A (0.40) HTR1ADRD2KDM4EALDH1A1PARP1
SCHEMBL7359345 0.83 HTR1A (0.47) HTR1ADRD2PARP1SIGMAR1DRD4
Hydrochloric Acid SCHEMBL7357103 0.83 HTR1A (0.47) HTR1ADRD2KDM4EPARP1SIGMAR1
SCHEMBL7353007 0.82 TRPV4 (0.45) HTR1AKDM4EALDH1A1MAPTPARP1
SCHEMBL7358512 0.82 TRPV4 (0.45) HTR1ADRD3DRD2KDM4EALDH1A1
SCHEMBL7359027 0.82 SIGMAR1 (0.45) HTR1ADRD3DRD2KDM4EPARP1
Hydrochloric Acid SCHEMBL7359064 0.82 SIGMAR1 (0.43) HTR1ADRD2KDM4EPARP1SIGMAR1
SCHEMBL7358547 0.82 TSHR (0.39) HTR1ADRD3KDM4EALDH1A1MAPT
SCHEMBL7360045 0.82 MAPT (0.52) HTR1ADRD3KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995003298-A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-02-02 WO disclosed